Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2016
A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia
Ivana Gojo, Jan H Beumer, Keith W Pratz, et al.
Nature Cancer
|
February 27, 2024
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity
Haojie Dong, Xin He, Lei Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2015
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
Yvette L Kasamon, Javier Bolaños-Meade, Gabrielle T Prince, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Aaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.
Haematologica
|
November 16, 2016
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
Shannon R McCurdy, Yvette L Kasamon, Christopher G Kanakry, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2017
NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018
Ruben A Mesa, Catriona Jamieson, Ravi Bhatia, et al.
Haematologica
|
May 8, 2025
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy
Jonathan A Webster, Madison Reed, Hua-Ling Tsai, et al.
Haematologica
|
August 28, 2025
C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi, et al.
Blood Advances
|
October 20, 2020
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide
Jonathan A Webster, Leo Luznik, Hua-Ling Tsai, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2016
A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia
Ivana Gojo, Jan H Beumer, Keith W Pratz, et al.
Nature Cancer
|
February 27, 2024
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity
Haojie Dong, Xin He, Lei Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2015
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
Yvette L Kasamon, Javier Bolaños-Meade, Gabrielle T Prince, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Aaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.
Haematologica
|
November 16, 2016
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
Shannon R McCurdy, Yvette L Kasamon, Christopher G Kanakry, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2017
NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018
Ruben A Mesa, Catriona Jamieson, Ravi Bhatia, et al.
Haematologica
|
May 8, 2025
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy
Jonathan A Webster, Madison Reed, Hua-Ling Tsai, et al.
Haematologica
|
August 28, 2025
C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi, et al.
Blood Advances
|
October 20, 2020
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide
Jonathan A Webster, Leo Luznik, Hua-Ling Tsai, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi, et al.
Page
of 13